MADISON, Wis.–(BUSINESS WIRE)–Promega Corporation announces availability of the first fully integrated Personal Automation™ System that meets regulatory requirements for clinical diagnostic DNA purification in the United States. The Maxwell® 16 System (photo attached) supports DNA-based tests performed by clinical labs, including sample preparation for human transplantation donor-matching tests done in HLA labs.
Currently, labs can face extreme pressure in delivering test results quickly enough to act on the transplant of an organ while it is still viable. With Maxwell 16, up to 16 DNA samples can be purified simultaneously in about 30 minutes with higher yield and more consistency than similar methods.
“Our intent is to support HLA transplant labs in their life-saving work by offering a purification method that handles more samples faster and more accurately than existing manual methods,” explains W. Gary Tarpley, Promega Vice President of R&D. “Medical Technologists need to have access to affordable automation that meets regulatory requirements for a general purpose medical device (in the United States) and allows them to deliver test results as quickly as possible.”
The Maxwell 16 System is:
A Maxwell 16 System can be ready for work in 15 minutes from delivery, and protocols take the touch of a button to initiate. The Maxwell unit sits on the bench top taking up only as much space as an open lap-top computer. For more information on Maxwell, please visit www.maxwell-16.com.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 1,450 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 12 countries and 54 global distributors. Annual sales exceed $200 million. For more information about Promega, visit www.promega.com.